Gross Jane A
Insider CIK 1684258 · LIFE Director · APVO See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATYR aTYR PHARMA INC | A Award deriv | 2026-05-11 | 2026-05-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ATYR aTYR PHARMA INC | A Award deriv | 2025-05-01 | 2025-05-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ATYR aTYR PHARMA INC | P Buy | 2025-03-17 | 2025-03-17 | 3,750 | $4.00 | $15.0K | 9,750 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2024-05-22 | 2024-05-23 | 24,000 | — | $0 | 24,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2023-05-17 | 2023-05-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| LIFE aTYR PHARMA INC | M Exercise deriv | 2023-04-26 | 2023-04-28 | 6,000 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | M Exercise | 2023-04-26 | 2023-04-28 | 6,000 | — | $0 | 6,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2022-04-26 | 2022-04-28 | 6,000 | — | $0 | 6,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2021-04-28 | 2021-04-29 | 1,428 | — | $0 | 1,428 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2021-01-29 | 2021-02-17 | 16,500 | — | $0 | 16,500 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2021-01-29 | 2021-02-17 | 5,500 | — | $0 | 5,500 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-27 | 2020-07-29 | 7,784 | — | $0 | 7,784 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 4,814 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 4,814 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 2,407 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 2,407 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 3,908 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 2,779 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 2,072 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-27 | 2020-07-29 | 2,140 | — | $0 | 2,140 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2020-05-06 | 2020-05-08 | 1,428 | — | $0 | 1,428 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-02-18 | 2020-03-19 | 134,800 | — | $0 | 134,800 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2019-11-01 | 2019-11-05 | 122,982 | — | $0 | 122,982 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2019-06-28 | 2019-07-02 | 2,285 | — | $0 | 2,285 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2019-03-01 | 2019-03-04 | 9,138 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2019-03-01 | 2019-03-04 | 9,138 | — | $0 | 112,293 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2019-03-01 | 2019-03-04 | 2,710 | $1.57 | $4.3K | 109,583 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2019-02-28 | 2019-03-04 | 67,400 | — | $0 | 67,400 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2018-03-09 | 2018-03-13 | 9,728 | — | $0 | 9,138 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2018-03-09 | 2018-03-13 | 67,400 | — | $0 | 67,400 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2018-03-09 | 2018-03-13 | 9,728 | — | $0 | 105,437 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2018-03-09 | 2018-03-13 | 2,282 | $3.13 | $7.1K | 103,155 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2018-03-01 | 2018-03-05 | 9,140 | — | $0 | 18,866 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2018-03-01 | 2018-03-05 | 9,140 | — | $0 | 95,709 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2018-02-03 | 2018-02-06 | 18,136 | — | $0 | 28,006 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2018-02-03 | 2018-02-06 | 18,136 | — | $0 | 86,569 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2017-08-01 | 2017-08-03 | 38,093 | — | $0 | 46,142 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2017-08-01 | 2017-08-03 | 10,076 | $1.83 | $18.4K | 68,433 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2017-08-01 | 2017-08-03 | 38,093 | — | $0 | 78,509 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2017-06-01 | 2017-06-01 | 33,700 | — | $0 | 33,700 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2017-03-10 | 2017-03-13 | 14,506 | — | $0 | 84,235 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2017-03-10 | 2017-03-13 | 3,837 | $1.78 | $6.8K | 40,416 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2017-03-10 | 2017-03-13 | 14,506 | — | $0 | 44,253 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2017-03-09 | 2017-03-13 | 9,727 | — | $0 | 98,741 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2017-03-09 | 2017-03-13 | 9,727 | — | $0 | 32,320 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2017-03-09 | 2017-03-13 | 2,573 | $1.80 | $4.6K | 29,747 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2017-03-01 | 2017-03-13 | 9,140 | — | $0 | 108,468 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2017-03-01 | 2017-03-13 | 9,140 | — | $0 | 25,011 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2017-03-01 | 2017-03-13 | 2,148 | $2.02 | $4.3K | 22,593 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2017-02-24 | 2017-02-27 | 33,700 | — | $0 | 156,339 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2017-02-03 | 2017-02-08 | 18,135 | — | $0 | 117,608 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2017-02-03 | 2017-02-08 | 18,135 | — | $0 | 21,793 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2017-02-03 | 2017-02-08 | 5,922 | $1.92 | $11.4K | 15,871 | SEC↗ |